MAPT and Alzheimer disease: Pathologically, AD is identified by the presence of extracellular amyloid plaques composed of aggregated Aß peptides and intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated, aggregated tau protein [1].